Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech award grant to support rapid, accurate, diagnosis of bacterial infection in animals

PBD Biotech Ltd has received a grant of £60,000 from the Greater Cambridge Greater Peterborough LEP’s Eastern Agri-Tech Growth Initiative to support its innovative technology for rapid, accurate and sensitive diagnosis of bacterial infection in animals.
  • June 7, 2017
  • Company
  • investment
Eastern Agri-Tech Innovation Fund

The company has been working on a method to detect the presence of Mycobacteria – which cause diseases such as bovine TB and Johne’s disease in cattle – in blood and milk samples. These bacterial infections have major consequences in terms of animal health and productivity and can also be passed to humans through infected food and dairy products and therefore are also a concern for public health. The limitations of current diagnostic methods make these diseases very difficult to control and therefore a new technology for the earlier detection of infected animals is urgently required.

Existing tests for infections caused by Mycobacteria monitor the animal’s immune response and can miss infection in early stages. In addition, commercial tests to monitor the immune response have only been developed for a limited number of animal species. Since the PBD technology directly detects the presence of the bacteria it can pick up the infection much earlier and be applied to any animal species, including domestic pets and exotic species in zoos.

The founders aim to use the funds from Eastern Agri-Tech Growth Initiative to fast-track their new technology into animal diagnostics for cattle, sheep, goats, companion animals and more. This will have a substantial positive impact on the industry, not only on animal health, but also by providing huge cost savings for animal health organisations, government agricultural departments, farmers, animal breeders and the food industry.

The grant will be used to catalyse the product research and development, and will create four new jobs.

Mark Reeve, Chairman of the Eastern Agri-Tech Growth Initiative Board and Greater Cambridge Greater Peterborough LEP, said: “This project will make important inroads in improving the efficiency of diagnosing livestock diseases that currently have a significant impact on the industry and beyond. Improving animal welfare is becoming increasingly important in the agricultural sector, which includes managing animals’ health and preventing the spread of disease. We look forward to seeing the results of this innovative project, and welcome the creation of new jobs in our area.”

Dr Berwyn Clarke, Chief Executive at PBD Biotech, said: “We are delighted to have secured this Eastern Agri-Tech Growth Initiative grant. This technology could transform the diagnosis of Tuberculosis in animals and potentially, in the future, in humans too. This is an enormous global commercial opportunity that should result in significant trade and job creation within East Anglia and this grant is invaluable to the company as it takes its first steps to building its business.”

The Eastern Agri-Tech Growth Initiative is run by the Greater Cambridge Greater Peterborough Enterprise Partnership (LEP) with support from New Anglia LEP, Norfolk County Council, Cambridgeshire County Council, and the local authorities covering this area. Grants are available to organisations looking to invest in specialist equipment, new market and supply chain development, ways to improve productivity and efficiency, and the application and commercialisation of Research and Development.

To find out how the Eastern Agri-Tech Growth Initiative could help to grow your business, visit the website or call the LEP on 01480 277180.

Share:

Related posts

Loading...
Actiphage

PBD Biotech gains attention of East of England Investment Catalyst among other investors

October 7, 2019
TB in humans and animals is a huge global problem as there is a lack of rapid, accurate ways to detect the disease at an early stage. PBD Biotech has developed Actiphage®, a new sensitive test that can detect the...
Actiphage

PBD Biotech gains attention of East of England Investment Catalyst among other investors

October 7, 2019
TB in humans and animals is a huge global problem as there is a lack of rapid, accurate ways to...
Blood test

International demand for first sensitive test for mycobacteria in blood or milk

August 15, 2018
Bovine TB is one of a group of diseases caused by mycobacteria that has devastated the agricultural industry worldwide. Now UK agri-tech start-up PBD Biotech, developers of the first rapid test for live mycobacteria, has secured £400,000 in its first...
Blood test

International demand for first sensitive test for mycobacteria in blood or milk

August 15, 2018
Bovine TB is one of a group of diseases caused by mycobacteria that has devastated the agricultural industry worldwide. Now...
Dr Berwyn Clarke at REAP

‘Angel investors bring more than money’ – Interview with PBD Biotech CEO

August 7, 2018
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for entrepreneurs, about the start-up’s strategic approach to securing the right investment for phage-based technology.
Dr Berwyn Clarke at REAP

‘Angel investors bring more than money’ – Interview with PBD Biotech CEO

August 7, 2018
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for...
New Anglia LEP CEO Chris Starkie and PBD Biotech CEO Berwyn Clarke

PBD Biotech gains funding to fuel overseas expansion

June 27, 2018
To meet the growing international demand for its rapid, sensitive test for mycobacterial disease, PBD Biotech is to establish a Canadian subsidiary in Saskatoon to support its first overseas commercial activity.
New Anglia LEP CEO Chris Starkie and PBD Biotech CEO Berwyn Clarke

PBD Biotech gains funding to fuel overseas expansion

June 27, 2018
To meet the growing international demand for its rapid, sensitive test for mycobacterial disease, PBD Biotech is to establish a...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More